LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 288 of 520
Next
>>
>
7176 to 7200 of 12982 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Normalized Growth Rate Inhibition Value
BT-20	Palbociclib	0.37	uM	LJP6	2	E16	72	hr	1334	3095	3899	0.7938	0.7226
BT-20	Palbociclib	0.37	uM	LJP6	3	E16	72	hr	1334	2891	3921	0.7372	0.6439
BT-20	Palbociclib	1.11	uM	LJP6	1	E15	72	hr	1334	1823	3955	0.4608	0.2201
BT-20	Palbociclib	1.11	uM	LJP6	2	E15	72	hr	1334	2460	3899	0.6309	0.4849
BT-20	Palbociclib	1.11	uM	LJP6	3	E15	72	hr	1334	2332	3921	0.5947	0.4318
BT-20	Palbociclib	3.33	uM	LJP6	1	E14	72	hr	1334	1675	3955	0.4234	0.1559
BT-20	Palbociclib	3.33	uM	LJP6	2	E14	72	hr	1334	2373	3899	0.6086	0.4507
BT-20	Palbociclib	3.33	uM	LJP6	3	E14	72	hr	1334	2353	3921	0.6001	0.4400
BT-20	Palbociclib	10	uM	LJP6	1	E13	72	hr	1334	1528	3955	0.3863	0.0901
BT-20	Palbociclib	10	uM	LJP6	2	E13	72	hr	1334	1765	3899	0.4527	0.1980
BT-20	Palbociclib	10	uM	LJP6	3	E13	72	hr	1334	1746	3921	0.4453	0.1886
BT-20	PF562271	0.04	uM	LJP6	1	F18	72	hr	1334	3655	3955	0.9240	0.9016
BT-20	PF562271	0.04	uM	LJP6	2	F18	72	hr	1334	3705	3899	0.9502	0.9350
BT-20	PF562271	0.04	uM	LJP6	3	F18	72	hr	1334	3815	3921	0.9729	0.9649
BT-20	PF562271	0.12	uM	LJP6	1	F17	72	hr	1334	3453	3955	0.8729	0.8339
BT-20	PF562271	0.12	uM	LJP6	2	F17	72	hr	1334	3305	3899	0.8476	0.7973
BT-20	PF562271	0.12	uM	LJP6	3	F17	72	hr	1334	3863	3921	0.9851	0.9808
BT-20	PF562271	0.37	uM	LJP6	1	F16	72	hr	1334	3278	3955	0.8287	0.7740
BT-20	PF562271	0.37	uM	LJP6	2	F16	72	hr	1334	3758	3899	0.9638	0.9529
BT-20	PF562271	0.37	uM	LJP6	3	F16	72	hr	1334	3763	3921	0.9596	0.9477
BT-20	PF562271	1.11	uM	LJP6	1	F15	72	hr	1334	2949	3955	0.7455	0.6583
BT-20	PF562271	1.11	uM	LJP6	2	F15	72	hr	1334	3038	3899	0.7792	0.7020
BT-20	PF562271	1.11	uM	LJP6	3	F15	72	hr	1334	3455	3921	0.8811	0.8436
BT-20	PF562271	3.33	uM	LJP6	1	F14	72	hr	1334	1967	3955	0.4973	0.2807
BT-20	PF562271	3.33	uM	LJP6	2	F14	72	hr	1334	2162	3899	0.5545	0.3660

|<
<<
Previous
Page 288 of 520
Next
>>
>
7176 to 7200 of 12982 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)